On October 7, Morgan Stanley fell 3.02% in regular trading, trading at $186.02/share, with Turnover of $53.4433 million. The dense downward revision of target prices by multiple investment banks directly catalyzed the decline.
Despite most institutions maintaining buy or neutral ratings, the concentrated target price cuts reflect converging expectations for the company's short-term earnings elasticity and valuation upside. UBS lowered its price target to $236 from $260 while keeping a buy rating, Rothschild & Co Redburn reduced it to $199 from $215 with a neutral rating, and Citigroup adjusted it to $210 from $235, also maintaining a neutral rating. The stock is set to report quarterly results on October 14, with consensus revenue expected at $20.057 billion, up 20.12% year over year.